Description

Oltar (glimepiride) tablets 4 mg. №30

Ingredients

Active ingredient: Glimepiride 4 mg.
Other ingredients: Lactose monohydrate, microcrystalline cellulose, povidone K30, sodium starch glycolate, and magnesium stearate.

Dosage

Recommended dosage: The usual starting dose is 1-2 mg once daily with breakfast or the first main meal. Dosage adjustments should be made based on blood glucose levels.

Indications

Oltar tablets are indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and weight reduction alone are not sufficient.

Contraindications

Do not use Oltar tablets in patients with a history of hypersensitivity to glimepiride or other sulfonylureas, or in patients with type 1 diabetes.

Directions

Take Oltar tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water.

Scientific Evidence

Glimepiride, the active ingredient in Oltar tablets, works by stimulating the release of insulin from the pancreas, thereby lowering blood sugar levels. Studies have shown that glimepiride is effective in reducing HbA1c levels and improving glycemic control in patients with type 2 diabetes.

Additional Information

It is important to monitor blood glucose levels regularly while taking Oltar tablets to ensure optimal control of diabetes. Inform your healthcare provider about all medications you are taking before starting Oltar to prevent potential drug interactions.

Pharmacological Effects: Glimepiride belongs to the sulfonylurea class of drugs and acts by increasing insulin release from pancreatic beta cells. This leads to improved glucose uptake by tissues and reduced hepatic glucose production.

Clinical Trials: Clinical trials have demonstrated the efficacy of Oltar tablets in lowering blood glucose levels and improving long-term glycemic control in patients with type 2 diabetes. One study published in the Journal of Diabetes Research showed a significant reduction in HbA1c levels after 12 weeks of treatment with glimepiride.